Aclaris Therapeutics
ACRS
ACRS
81 hedge funds and large institutions have $31.4M invested in Aclaris Therapeutics in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less capital invested
Capital invested by funds: $78M → $31.4M (-$46.6M)
98% less call options, than puts
Call options by funds: $1K | Put options by funds: $46K
Holders
81
Holding in Top 10
–
Calls
$1K
Puts
$46K
Top Buyers
| 1 | +$1.81M | |
| 2 | +$1.75M | |
| 3 | +$1.69M | |
| 4 |
Renaissance Technologies
New York
|
+$1.37M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.02M |
Top Sellers
| 1 | -$8.72M | |
| 2 | -$8.42M | |
| 3 | -$3.61M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.26M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.12M |